Compound Detail
CHEMBL2332869
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL2332869 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | GBJNDWYKXHMGPB-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
430.4
MW (Da)
4.69
ALogP
6
HBA
3
HBD
114.0
PSA (Ų)
0.42
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 7.27
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | IC50 | 7.27 | 7.27 | 54.0 | 1 |
| Vascular endothelial growth factor receptor 2 CHEMBL2331049 | IC50 | 4.75 | 4.75 | 17760.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Receptor-type tyrosine-protein kinase FLT3 | IC50 | = | 54.0 | nM | 7.27 | Inhibition of FLT3-ITD mutant in human MV4-11 cells assessed as decrease in cell... | 23362959 |
| Vascular endothelial growth factor receptor 2 | IC50 | = | 17760.0 | nM | 4.75 | Inhibition of VEGFR2 in transgenic zebrafish embryo assessed as inhibition of in... | 23362959 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 23362959 | 10.1021/jm301537p | Vascular endothelial growth factor receptor 2 | 1 |
| 23362959 | 10.1021/jm301537p | HeLa | 1 |
| 23362959 | 10.1021/jm301537p | Receptor-type tyrosine-protein kinase FLT3 | 1 |
Data from ChEMBL 36 via Core Engine